` Comparison: IPA vs 207940 - Alpha Spread

IPA
vs
207940

Over the past 12 months, IPA has underperformed Samsung Biologics Co Ltd, delivering a return of 0% compared to the Samsung Biologics Co Ltd's +78% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
IPA
207940
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

IPA Intrinsic Value
HIDDEN
Show
Samsung Biologics Co Ltd Intrinsic Value
HIDDEN
Show
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Immunoprecise Antibodies Ltd
XTSX:IPA
6.5 CAD
Samsung Biologics Co Ltd
KRX:207940
1 780 000 KRW
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
IPA, 207940

IPA
207940
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Immunoprecise Antibodies Ltd
Revenue
Samsung Biologics Co Ltd
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
IPA, 207940

IPA
207940
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Immunoprecise Antibodies Ltd
XTSX:IPA
Samsung Biologics Co Ltd
KRX:207940
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

IPA
55%
Samsung Biologics Co Ltd
56.3%

Operating Margin

IPA
-79%
Samsung Biologics Co Ltd
36.6%

Net Margin

IPA
-90%
Samsung Biologics Co Ltd
29%

FCF Margin

IPA
-58%
Samsung Biologics Co Ltd
13.1%

ROE

IPA
-35.9%
Samsung Biologics Co Ltd
14%

ROA

IPA
-30.3%
Samsung Biologics Co Ltd
9.3%

ROIC

IPA
-70.6%
Samsung Biologics Co Ltd
10.1%

ROCE

IPA
-30.4%
Samsung Biologics Co Ltd
14.9%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
IPA, 207940

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
IPA, 207940

Performance Gap Between IPA and 207940
HIDDEN
Show

Performance By Year
IPA, 207940

Loading
IPA
207940
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare IPA to other stocks
Custom
Choose any stock to compare
Unlock Full Access to Alpha Spread
Create Free Account